US Patent Issued to AICURIS ANTI-INFECTIVE CURES on April 15 for "Methods for screening and identifying agents that inhibit or modulate the nuclear egress complex of herpesviruses" (German Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,276,665, issued on April 15, was assigned to AICURIS ANTI-INFECTIVE CURES AG (Wuppertal, Germany).

"Methods for screening and identifying agents that inhibit or modulate the nuclear egress complex of herpesviruses" was invented by Manfred Marschall (Nuremberg, Germany), Yves Muller (Erlangen, Germany), Heinrich Sticht (Furth, Germany) and Jutta Eichler (Erlangen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention generally provides for a novel NEC-targeted strategy for the development of antiherpesviral drugs as well as for a novel antiviral strategy targeting the viral-cellular nuclear egress complex (NEC) for a small molecule-...